CO4960660A1 - Derivados de 5-aroil-pirrol-2-ilmetilareno, composiciones farmaceuticas que las contienen y metodos para la preparacion de estos compuestos - Google Patents
Derivados de 5-aroil-pirrol-2-ilmetilareno, composiciones farmaceuticas que las contienen y metodos para la preparacion de estos compuestosInfo
- Publication number
- CO4960660A1 CO4960660A1 CO97029326A CO97029326A CO4960660A1 CO 4960660 A1 CO4960660 A1 CO 4960660A1 CO 97029326 A CO97029326 A CO 97029326A CO 97029326 A CO97029326 A CO 97029326A CO 4960660 A1 CO4960660 A1 CO 4960660A1
- Authority
- CO
- Colombia
- Prior art keywords
- alkyl
- ilmetilareno
- aroil
- pirrol
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/33—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/333—Radicals substituted by oxygen or sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Pulmonology (AREA)
- Transplantation (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Un compuesto de la fórmula I: en donde: R1 y R5 son independientemente H o alquilo, o R1 y R5 juntos son -(CH2 )2 - o -(CH2 )3 ; R3 y R4 son, independientemente, H, halo, alquilo, alquiloxilo, o alquiltio; R10 es un grupo representado por la fórmula (A), (B) o (C): en donde: X es O o S; R12 y R16 son independientemente H, halo, alquilo, alquiloxilo, alquiltio, ciano, o hidroxilo; R13 y R15 son independientemente H, halo, alquilo, alquiloxilo o alquiltio; y R14 es H, halo, alquilo, haloalquilo, amino, alquil-amino, dialquilamino, alquiloxilo, hidroxilo, alquiltio, alquenilo, alquinilo, ciano, -SO2 R17 , en donde R17 es alquilo, o -SO2 NR18 R19 en donde R18 y R19 son independientemente H o alquilo; con la condición de que por lo menos dos de R12 , R13 , R14 , R15 , y R16 son H, y de que si solo dos de R12 , R13 , R14 , R15 , y R16 son H, los sustituyentes no hidrógeno no están todos adyacentes; o R12 , R15 , R16 son H y R13 y R14 juntos con -OCH2 O-;...
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US1869196P | 1996-05-30 | 1996-05-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
CO4960660A1 true CO4960660A1 (es) | 2000-09-25 |
Family
ID=21789298
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO97029326A CO4960660A1 (es) | 1996-05-30 | 1997-05-28 | Derivados de 5-aroil-pirrol-2-ilmetilareno, composiciones farmaceuticas que las contienen y metodos para la preparacion de estos compuestos |
Country Status (21)
Country | Link |
---|---|
US (3) | US5952368A (es) |
EP (1) | EP0906279B1 (es) |
JP (1) | JP3142581B2 (es) |
KR (1) | KR100303377B1 (es) |
CN (1) | CN1225629A (es) |
AR (1) | AR007297A1 (es) |
AT (1) | ATE225333T1 (es) |
AU (1) | AU717602B2 (es) |
BR (1) | BR9709497A (es) |
CA (1) | CA2256609C (es) |
CO (1) | CO4960660A1 (es) |
DE (1) | DE69716061T2 (es) |
DK (1) | DK0906279T3 (es) |
ES (1) | ES2182090T3 (es) |
HR (1) | HRP970296A2 (es) |
MA (1) | MA24346A1 (es) |
PT (1) | PT906279E (es) |
TR (1) | TR199802456T2 (es) |
TW (1) | TW415946B (es) |
WO (1) | WO1997046524A1 (es) |
ZA (1) | ZA974538B (es) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7112606B2 (en) * | 2002-01-30 | 2006-09-26 | Amgen Inc. | Heterocyclic arylsulfonamidobenzylic compounds |
TWI372050B (en) * | 2003-07-03 | 2012-09-11 | Astex Therapeutics Ltd | (morpholin-4-ylmethyl-1h-benzimidazol-2-yl)-1h-pyrazoles |
WO2005123671A1 (ja) * | 2004-06-22 | 2005-12-29 | Taisho Pharmaceutical Co., Ltd. | ピロール誘導体 |
TWI427077B (zh) * | 2004-12-30 | 2014-02-21 | Astex Therapeutics Ltd | 吡唑化合物及其用途和含有彼之藥學組成物 |
JP5474354B2 (ja) * | 2005-12-30 | 2014-04-16 | アステックス、セラピューティックス、リミテッド | 医薬化合物 |
US8435970B2 (en) * | 2006-06-29 | 2013-05-07 | Astex Therapeutics Limited | Pharmaceutical combinations of 1-cyclopropyl-3-[3-(5-morpholin-4-ylmethyl-1H-benzoimidazol-2-yl)-1H-pyrazol-4-yl]-urea |
JP2009542608A (ja) * | 2006-06-29 | 2009-12-03 | アステックス・セラピューティクス・リミテッド | 医薬組合せ剤 |
US10358408B2 (en) * | 2017-12-22 | 2019-07-23 | Polycarbon Industries, Inc. | Synthesis of azelaic acid |
CA3209491A1 (en) | 2021-03-15 | 2022-09-22 | Saul Yedgar | Hyaluronic acid-conjugated dipalmitoyl phosphatidyl ethanolamine in combination with non-steroidal anti-inflammatory drugs (nsaids) for treating or alleviating inflammatory disease |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3752826A (en) * | 1970-01-26 | 1973-08-14 | Mcneilab Inc | Aroyl substituted pyrroles |
US4089969A (en) * | 1976-07-14 | 1978-05-16 | Syntex (U.S.A.) Inc. | 5-Aroyl-1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-1-carboxylic acid derivatives and process for the production thereof |
DK328382A (da) * | 1981-07-22 | 1983-01-23 | Syntex Inc | Fremgangsmaade til fremstilling af antihypertensive midler |
IL86462A (en) * | 1987-05-29 | 1992-12-01 | Fujisawa Pharmaceutical Co | Alkanesulfonanilide derivatives, processes for preparation thereof and pharmaceutical compositions comprising the same |
US5622948A (en) * | 1994-12-01 | 1997-04-22 | Syntex (U.S.A.) Inc. | Pyrrole pyridazine and pyridazinone anti-inflammatory agents |
-
1997
- 1997-05-21 WO PCT/EP1997/002587 patent/WO1997046524A1/en active IP Right Grant
- 1997-05-21 AT AT97925931T patent/ATE225333T1/de not_active IP Right Cessation
- 1997-05-21 PT PT97925931T patent/PT906279E/pt unknown
- 1997-05-21 ES ES97925931T patent/ES2182090T3/es not_active Expired - Lifetime
- 1997-05-21 TR TR1998/02456T patent/TR199802456T2/xx unknown
- 1997-05-21 CA CA002256609A patent/CA2256609C/en not_active Expired - Fee Related
- 1997-05-21 AU AU30913/97A patent/AU717602B2/en not_active Ceased
- 1997-05-21 JP JP10500147A patent/JP3142581B2/ja not_active Expired - Fee Related
- 1997-05-21 BR BR9709497A patent/BR9709497A/pt unknown
- 1997-05-21 KR KR1019980709759A patent/KR100303377B1/ko not_active IP Right Cessation
- 1997-05-21 DK DK97925931T patent/DK0906279T3/da active
- 1997-05-21 CN CN97196566A patent/CN1225629A/zh active Pending
- 1997-05-21 EP EP97925931A patent/EP0906279B1/en not_active Expired - Lifetime
- 1997-05-21 DE DE69716061T patent/DE69716061T2/de not_active Expired - Fee Related
- 1997-05-23 ZA ZA9704538A patent/ZA974538B/xx unknown
- 1997-05-27 AR ARP970102246A patent/AR007297A1/es not_active Application Discontinuation
- 1997-05-28 CO CO97029326A patent/CO4960660A1/es unknown
- 1997-05-28 US US08/864,703 patent/US5952368A/en not_active Expired - Fee Related
- 1997-05-28 HR HR60/018,691A patent/HRP970296A2/xx not_active Application Discontinuation
- 1997-05-29 TW TW086107344A patent/TW415946B/zh not_active IP Right Cessation
- 1997-05-30 MA MA24642A patent/MA24346A1/fr unknown
-
1999
- 1999-03-24 US US09/275,542 patent/US6136844A/en not_active Expired - Fee Related
- 1999-03-24 US US09/275,540 patent/US6127402A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
DE69716061T2 (de) | 2003-08-14 |
AU717602B2 (en) | 2000-03-30 |
AU3091397A (en) | 1998-01-05 |
PT906279E (pt) | 2003-02-28 |
DE69716061D1 (de) | 2002-11-07 |
AR007297A1 (es) | 1999-10-27 |
EP0906279A1 (en) | 1999-04-07 |
DK0906279T3 (da) | 2003-02-03 |
ZA974538B (en) | 1997-12-01 |
TR199802456T2 (xx) | 1999-02-22 |
ES2182090T3 (es) | 2003-03-01 |
US6136844A (en) | 2000-10-24 |
KR20000016191A (ko) | 2000-03-25 |
TW415946B (en) | 2000-12-21 |
CN1225629A (zh) | 1999-08-11 |
WO1997046524A1 (en) | 1997-12-11 |
JPH11511755A (ja) | 1999-10-12 |
CA2256609C (en) | 2005-07-26 |
BR9709497A (pt) | 1999-08-10 |
MA24346A1 (fr) | 1998-07-01 |
ATE225333T1 (de) | 2002-10-15 |
US5952368A (en) | 1999-09-14 |
US6127402A (en) | 2000-10-03 |
HRP970296A2 (en) | 1998-04-30 |
CA2256609A1 (en) | 1997-12-11 |
EP0906279B1 (en) | 2002-10-02 |
KR100303377B1 (ko) | 2001-12-12 |
JP3142581B2 (ja) | 2001-03-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE19575012I2 (de) | Carboxyalkyl-Dipeptide Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel | |
ATE315567T1 (de) | A-1-adenosin rezeptor antagoniste | |
BR9607017A (pt) | Composto e uso do mesmo | |
DE3781716T2 (de) | Mittel zur ortsspezifischen alkylierung. | |
ES2053508T3 (es) | Compuestos de acidos 3-pirrolidinil-tio-1-azabiciclo(3.2.0)hept-2-eno-2-carboxilicos. | |
DK0665844T3 (da) | Substituerede benzylaminoquinuclidinforbindelser som antagonister af substans P | |
DK0870768T3 (da) | Azaindol-ethylaminderivater som nikotinacetylcholinreceptor-bindingsmidler | |
DK0918776T3 (da) | Totalsyntese af antitumor acylfulvener | |
IL79830A0 (en) | Nitromethylene derivatives,their preparation and their use as insecticides | |
HUP9902576A1 (hu) | Új eritromicinszármazékok, eljárás előállításukra és alkalmazásuk gyógyászati készítményekben | |
PT81855B (pt) | Processo de preparacao de arilciclobutilalquilaminas e de composicoes farmaceuticas que as contem | |
DK0659417T3 (da) | Fremgangsmåder til inhibering af dysfunktionel blødning fra livmoderen | |
CO4960660A1 (es) | Derivados de 5-aroil-pirrol-2-ilmetilareno, composiciones farmaceuticas que las contienen y metodos para la preparacion de estos compuestos | |
ES2163723T3 (es) | Nuevos compuestos moduladores de los receptores hormonales, las composiciones que los incluyen y su utilizacion en terapia. | |
DE69031913D1 (de) | Antivirale mittel | |
ES2182114T3 (es) | Derivados azabiciclicos de la carbamoiloxi-multilina para empleo antibacteriano. | |
PT81794B (pt) | Processo de preparacao de novos derivados da pristinamicina iib e das suas composicoes farmaceuticas | |
KR900016178A (ko) | 2-치환 n,n'-디트리메톡시벤조일 피페라진, 그의 제조 방법 및 그를 함유하는 치료 조성물 | |
UA66748C2 (en) | Phenyl substituted 4-azasteroids fluroderivatives, methods for the preparation thereof (variants) and pharmaceutical composition based thereon | |
SE8303913L (sv) | Heterocykliska foreningar | |
AR004949A1 (es) | Derivados de benzoil-4-pirazol, procedimiento para obtenerlos, composiciones herbicidas que los contienen y procedimientos para combatirplantas indeseables. | |
HRP20000027B1 (en) | Process for the preparation of alkoxyfuranoneamine derivatives, compounds obtained by this process, and the use of these compounds | |
EA199800083A1 (ru) | Производные 1,3-оксазин-4-она в качестве гербицидов | |
DE69521895T2 (de) | Indolderivate als prodrugs von "5-ht1-like" rezeptor agonisten | |
EA200001157A2 (ru) | Новые замещенные производные (дигидро)бензоксазина и (дигидро)бензотиазина, способ их получения и содержащие их фармацевтические композиции |